Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lucentis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

Bayer files Eylea for diabetes complication in EU

Bayer files Eylea for diabetes complication in EU Looks to keep with Novartis’ Lucentis. Bayer is trying to win approval for a third indication for its big-selling eye disease treatment Eylea, namely the treatment of diabetic macular edema ... Eylea has a slight dosing advantage over Lucentis as it is

Novartis' Lucentis wins fourth NICE recommendation

Novartis' Lucentis wins fourth NICE recommendation Even more NHS patients in England and Wales are set to have access to Novartis' Lucentis after the drug was backed as the first medicine recommended to treat leaking blood vessels ... NICE's appraisal committee agreed that Lucentis was superior to

NICE backs Novartis/ ThromboGenics’ eye drug

NICE backs Novartis/ ThromboGenics’ eye drug The recommendation is the latest in a busy year for Novartis in the UK, which includes the expansion of the NICE-recommended uses of its big-selling eye condition drug Lucentis

Bayer wins new Eylea approval in Europe

Bayer wins new Eylea approval in Europe Macular oedema indication will provide more competition for Novartis’ Lucentis. Bayer's ambitions for Eylea continue apace after the drug was approved in a second eye disorder indication in Europe. ... The approval means Eylea will be even more of a

NICE gives final backing to drugs from Bayer, GSK and Otsuka

NICE gives final backing to drugs from Bayer, GSK and Otsuka There are estimated to be about 26, 000 new cases of wet AMD in the UK each year and patients already have access to Novartis' Lucentis (ranibizumab), which has become the ... Under NICE's recommendation, Eylea is restricted to the same use as Lucentis,

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...
Is communication failing us?
Compelling people to care in a world oversaturated with news and information...